SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Pliant Therapeutics Q3 net loss narrows on lower expenses

Pliant Therapeutics Q3 net loss narrows on lower expenses Overview US biopharma firm's Q3 net loss n

PLRX

Related stories